Stop TPO-receptor agonist in ITP Patients
Phase 4
Completed
- Conditions
- immune trombocytopeniaITP1003553410003816
- Registration Number
- NL-OMON54835
- Lead Sponsor
- Hagaziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Persistent or chronic ITP, 18 years old, in need of second line therapy after
initial treatment with corticosteroids, informed consent
Exclusion Criteria
Previous splenectomy, Bone marrow disease, Other bleeding disorder, Liver
disease (Child Pugh above 7), Pregnancy, Secondary ITP, prior TPO-RA use
(longer than 3 months of therapy)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method